Frontline Immunotherapy in Non-Small Cell Lung Cancer: For Which Patients Is Platinum Passe?

J Zweig; SK Padda

Frontline Immunotherapy in Non-Small Cell Lung Cancer: For Which Patients Is Platinum Passe?

Hematology Oncology

Research output: Contribution to journal › Article › peer-review

Original language	American English
Pages (from-to)	16-20
Number of pages	5
Journal	American Journal of Hematology-oncology
Volume	13
Issue number	7
State	Published - Jul 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{04407f37d4e346bd865fcd2e2f76a9ee,

title = "Frontline Immunotherapy in Non-Small Cell Lung Cancer: For Which Patients Is Platinum Passe?",

author = "J Zweig and SK Padda",

year = "2017",

month = jul,

language = "American English",

volume = "13",

pages = "16--20",

journal = "American Journal of Hematology-oncology",

issn = "1939-6163",

publisher = "U. S. Healthcare Communications LLC",

number = "7",

}

TY - JOUR

T1 - Frontline Immunotherapy in Non-Small Cell Lung Cancer

T2 - For Which Patients Is Platinum Passe?

AU - Zweig, J

AU - Padda, SK

PY - 2017/7

Y1 - 2017/7

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:000410834700005&DestLinkType=FullRecord&DestApp=WOS

M3 - Article

SN - 1939-6163

VL - 13

SP - 16

EP - 20

JO - American Journal of Hematology-oncology

JF - American Journal of Hematology-oncology

IS - 7

ER -

Frontline Immunotherapy in Non-Small Cell Lung Cancer: For Which Patients Is Platinum Passe?

UN SDGs

Other files and links

Fingerprint

Cite this